Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ERTAPENEM Cause Clostridium difficile infection? 57 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 57 reports of Clostridium difficile infection have been filed in association with ERTAPENEM (INVANZ). This represents 1.4% of all adverse event reports for ERTAPENEM.

57
Reports of Clostridium difficile infection with ERTAPENEM
1.4%
of all ERTAPENEM reports
6
Deaths
51
Hospitalizations

How Dangerous Is Clostridium difficile infection From ERTAPENEM?

Of the 57 reports, 6 (10.5%) resulted in death, 51 (89.5%) required hospitalization, and 4 (7.0%) were considered life-threatening.

Is Clostridium difficile infection Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ERTAPENEM. However, 57 reports have been filed with the FAERS database.

What Other Side Effects Does ERTAPENEM Cause?

Drug ineffective (1,001) Macular degeneration (776) Off label use (372) Product use in unapproved indication (346) Pyrexia (279) Nausea (277) Confusional state (263) Pain (255) Malaise (220) Weight decreased (220)

What Other Drugs Cause Clostridium difficile infection?

ADALIMUMAB (1,502) INFLIXIMAB (1,419) VEDOLIZUMAB (1,130) LENALIDOMIDE (814) VANCOMYCIN (743) METRONIDAZOLE (619) PREDNISONE (618) METHOTREXATE (588) RITUXIMAB (532) CIPROFLOXACIN (508)

Which ERTAPENEM Alternatives Have Lower Clostridium difficile infection Risk?

ERTAPENEM vs ERTUGLIFLOZIN PIDOLATE ERTAPENEM vs ERYTHROMYCIN ERTAPENEM vs ERYTHROMYCIN ETHYLSUCCINATE ERTAPENEM vs ERYTHROMYCIN LACTOBIONATE ERTAPENEM vs ERYTHROPOIETIN

Related Pages

ERTAPENEM Full Profile All Clostridium difficile infection Reports All Drugs Causing Clostridium difficile infection ERTAPENEM Demographics